<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TB R&#38;D Matters Blog &#187; TB News</title>
	<atom:link href="http://www.newtbdrugs.org/blog/category/tb-news/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.newtbdrugs.org/blog</link>
	<description>Working Towards a Faster Cure for Tuberculosis</description>
	<lastBuildDate>Sat, 19 May 2012 12:57:01 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Watch Video from the World TB Day Congressional Briefing</title>
		<link>http://www.newtbdrugs.org/blog/watch-video-from-the-world-tb-day-congressional-briefing/</link>
		<comments>http://www.newtbdrugs.org/blog/watch-video-from-the-world-tb-day-congressional-briefing/#comments</comments>
		<pubDate>Tue, 01 May 2012 18:02:10 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[aeras]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[usa]]></category>
		<category><![CDATA[usaid]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3780</guid>
		<description><![CDATA[A briefing and update on tuberculosis (TB), a disease that is curable but still takes the lives of 4,000 people each day and is the number one killer of people living with HIV.  Links to video included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/watch-video-from-the-world-tb-day-congressional-briefing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stop TB News &#8211; April 2012</title>
		<link>http://www.newtbdrugs.org/blog/stop-tb-news-april-2012/</link>
		<comments>http://www.newtbdrugs.org/blog/stop-tb-news-april-2012/#comments</comments>
		<pubDate>Tue, 01 May 2012 13:40:15 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[stop tb partnership]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3775</guid>
		<description><![CDATA[The latest news from the Stop TB Partnership as of April 2012.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/stop-tb-news-april-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Update: Strategies for Early and Late Stage Drug Development</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-update-strategies-for-early-and-late-stage-drug-development/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-update-strategies-for-early-and-late-stage-drug-development/#comments</comments>
		<pubDate>Wed, 11 Apr 2012 19:13:03 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[global health]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3704</guid>
		<description><![CDATA[This week, we are highlighting two articles published online in the Journal of Infectious Diseases in March.  The first article by Coxon, et al., looks at the benefits and limitations of the two main approaches to compound discovery for TB, target-based and phenotypic-based.  The second article by Phillips, et al., would like TB clinical trialists to consider new strategies or designs for evaluating TB drug regimens which could alleviate a bottleneck as new drugs and consequently new potential drug combinations move into clinical testing.  Additional links to TB R&#038;D publications and news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-update-strategies-for-early-and-late-stage-drug-development/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Working Group on New TB Drugs Launches Strategic Plan 2011-2015</title>
		<link>http://www.newtbdrugs.org/blog/working-group-on-new-tb-drugs-launches-strategic-plan-2011-2015/</link>
		<comments>http://www.newtbdrugs.org/blog/working-group-on-new-tb-drugs-launches-strategic-plan-2011-2015/#comments</comments>
		<pubDate>Thu, 29 Mar 2012 15:12:38 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[wgnd]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3680</guid>
		<description><![CDATA[The WGND Strategic Plan 2011-2015 is an update of the "New Drugs" section of the Global Plan to Stop TB: 2011-2015. It describes the progress, gaps, and vision of the WGND and the TB drug development field as a whole. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/working-group-on-new-tb-drugs-launches-strategic-plan-2011-2015/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Update:  243rd American Chemistry Society Conference</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-update-243rd-american-chemistry-society-conference/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-update-243rd-american-chemistry-society-conference/#comments</comments>
		<pubDate>Tue, 27 Mar 2012 20:50:45 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Early Drug Development]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[acs]]></category>
		<category><![CDATA[aeras]]></category>
		<category><![CDATA[chemistry]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[vaccines]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3671</guid>
		<description><![CDATA[The 243rd American Chemistry Society National Meeting and Exposition is being held in San Diego, California, from March 26 to March 29.  There are several presentations on tuberculosis.  Here are the abstracts of a few of the talks.  The first item received news coverage and discusses two approved antibiotics that may prove effective in treating TB.  Additional links to TB R&#038;D News are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-update-243rd-american-chemistry-society-conference/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>World TB Day!  Overview of Events, News and Messages</title>
		<link>http://www.newtbdrugs.org/blog/world-tb-day-overview-of-events-news-and-messages/</link>
		<comments>http://www.newtbdrugs.org/blog/world-tb-day-overview-of-events-news-and-messages/#comments</comments>
		<pubDate>Fri, 23 Mar 2012 18:53:40 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[vaccines]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[world tb day]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3614</guid>
		<description><![CDATA[Saturday, March 24, is officially World TB Day but there has been a stream of activities, publications, news and messages to let the world not forget about this major infectious disease killer that claims millions of lives each year.  We present links and summaries of events, publications, messages, and news coverage leading up to World TB Day.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/world-tb-day-overview-of-events-news-and-messages/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>World TB Day Coverage: New Combo TB Drug Trial Announced</title>
		<link>http://www.newtbdrugs.org/blog/world-tb-day-coverage-new-combo-tb-drug-trial-announced/</link>
		<comments>http://www.newtbdrugs.org/blog/world-tb-day-coverage-new-combo-tb-drug-trial-announced/#comments</comments>
		<pubDate>Wed, 21 Mar 2012 17:12:21 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[cptr]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[nih/niaid]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[usaid]]></category>
		<category><![CDATA[vaccines]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3571</guid>
		<description><![CDATA[During the "Cure All: A briefing on the status of the most promising new TB drugs research" sponsored by the Critical Path to New TB Drug Regimens (CPTR) on Monday, March 19, Dr. Mel Spigelman, CEO &#038; President, of TB Alliance announced the launch of the NC002 trial, a combination drug trial that establishes a new pathway to TB and multi-drug resistant TB treatment. The meeting also involved high-level officials from U.S. agencies that support TB research including Anthony Fauci (Director, NIAID/NIH), Janet Woodcock (Director, CDER/FDA), and Robert Clay (Deputy Assistant Administrator, Global Health Bureau/USAID). ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/world-tb-day-coverage-new-combo-tb-drug-trial-announced/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  Results from Preventative Therapy Trial in SA Miners</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-results-from-preventative-therapy-trial-in-sa-miners/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-results-from-preventative-therapy-trial-in-sa-miners/#comments</comments>
		<pubDate>Fri, 09 Mar 2012 16:54:53 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[aurum]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[croi]]></category>
		<category><![CDATA[isoniazid]]></category>
		<category><![CDATA[london school]]></category>
		<category><![CDATA[miners]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[preventative therapy]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3555</guid>
		<description><![CDATA[At the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, results on the Thibela TB preventative therapy trial in South Africa gold miners  was presented with mixed outcomes.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-results-from-preventative-therapy-trial-in-sa-miners/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Death of TB Champion, Rep. Donald Payne</title>
		<link>http://www.newtbdrugs.org/blog/death-of-tb-champion-rep-donald-payne/</link>
		<comments>http://www.newtbdrugs.org/blog/death-of-tb-champion-rep-donald-payne/#comments</comments>
		<pubDate>Tue, 06 Mar 2012 17:54:43 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[usa]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3546</guid>
		<description><![CDATA[U.S. Representative Donald Payne from New Jersey died Tuesday, March 6.  He will be remembered as a great champion of TB as well as malaria and HIV/AIDS.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/death-of-tb-champion-rep-donald-payne/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  CSU Identifies Anti-TB Compound against Unique Target</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-csu-identifies-anti-tb-compound-against-unique-target/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-csu-identifies-anti-tb-compound-against-unique-target/#comments</comments>
		<pubDate>Thu, 23 Feb 2012 21:45:26 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[Funding Opportunities]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[usa]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3502</guid>
		<description><![CDATA[This week's article highlights research out of Colorado State University that identifies a potential anti-TB compound against a unique target-- the inner membrane transporter MmpL3 of Mycobacterium tuberculosis--that inhibits an essential cell function of the mycobacteria.  Additional links to TB R&#038;D News are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-csu-identifies-anti-tb-compound-against-unique-target/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

